Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Denali Therapeutics (DNLI) Asset Utilization Ratio (2018 - 2024)

Denali Therapeutics (DNLI) has disclosed Asset Utilization Ratio for 7 consecutive years, with 0.0 as the latest value for Q2 2024.

  • Quarterly Asset Utilization Ratio fell 99.67% to 0.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was 0.0 through Jun 2024, down 99.67% year-over-year, with the annual reading at 0.25 for FY2023, 233.91% up from the prior year.
  • Asset Utilization Ratio for Q2 2024 was 0.0 at Denali Therapeutics, down from 0.22 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.28 in Q4 2023, with the low at 0.0 in Q2 2024.
  • Average Asset Utilization Ratio over 5 years is 0.08, with a median of 0.04 recorded in 2020.
  • The sharpest move saw Asset Utilization Ratio surged 665.75% in 2022, then tumbled 99.67% in 2024.
  • Over 5 years, Asset Utilization Ratio stood at 0.01 in 2020, then soared by 46.44% to 0.01 in 2021, then soared by 466.26% to 0.08 in 2022, then surged by 243.52% to 0.28 in 2023, then plummeted by 99.7% to 0.0 in 2024.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.0, 0.22, and 0.28 for Q2 2024, Q1 2024, and Q4 2023 respectively.